Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis

被引:141
作者
Mohan, Man [1 ]
Lin, Chengqi [1 ]
Guest, Erin [1 ,2 ]
Shilatifard, Ali [1 ]
机构
[1] Stowers Inst Med Res, Kansas City, MO 64110 USA
[2] Childrens Mercy Hosp, Kansas City, MO 64108 USA
关键词
RNA-POLYMERASE-II; ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; PROTO-ONCOPROTEIN MLL; HISTONE METHYLTRANSFERASE COMPLEX; TRANSCRIPTIONAL ELONGATION; GENE-EXPRESSION; H3K4; METHYLATION; CHROMATIN MODIFICATION; DROSOPHILA-TRITHORAX;
D O I
10.1038/nrc2915
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The RNA polymerase II (Pol II) elongation factor (ELL) was the first translocation partner of mixed lineage leukaemia (MLL) for which a biochemical function was determined. It was therefore proposed that the regulation of the elongation stage of transcription could be fundamental to MLL-based leukaemogenesis. Recent studies have identified ELL complexed with several of the translocation partners of MLL in a transcriptional super elongation complex (SEC). These studies provide evidence for the importance of the regulation of Pol II elongation in disease pathogenesis and suggest that MLL chimaeras function by licensing Pol II transcription elongation without the appropriate checkpoints.
引用
收藏
页码:720 / 728
页数:9
相关论文
共 90 条
[21]   Dynamic regulation of histone H3 methylated at lysine 79 within a tissue-specific chromatin domain [J].
Im, H ;
Park, C ;
Feng, Q ;
Johnson, KD ;
Kiekhaefer, CM ;
Choi, K ;
Zhang, Y ;
Bresnick, EH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (20) :18346-18352
[22]   TRITHORAX - A NEW HOMOEOTIC MUTATION OF DROSOPHILA-MELANOGASTER CAUSING TRANSFORMATIONS OF ABDOMINAL AND THORACIC IMAGINAL SEGMENTS .1. PUTATIVE ROLE DURING EMBRYOGENESIS [J].
INGHAM, P ;
WHITTLE, R .
MOLECULAR AND GENERAL GENETICS, 1980, 179 (03) :607-614
[23]   The significance of the Wnt pathway in the pathology of human cancers [J].
Karim, RZ ;
Tse, GMK ;
Putti, TC ;
Scolyer, RA ;
Lee, CS .
PATHOLOGY, 2004, 36 (02) :120-128
[24]   Prognostic Factors in Adult Patients up to 60 Years Old With Acute Myeloid Leukemia and Translocations of Chromosome Band 11q23: Individual Patient Data-Based Meta-Analysis of the German Acute Myeloid Leukemia Intergroup [J].
Krauter, Juergen ;
Wagner, Katharina ;
Schaefer, Irina ;
Marschalek, Rolf ;
Meyer, Claus ;
Heil, Gerhard ;
Schaich, Markus ;
Ehninger, Gerhard ;
Niederwieser, Dietger ;
Krahl, Rainer ;
Buechner, Thomas ;
Sauerland, Cristina ;
Schlegelberger, Brigitte ;
Doehner, Konstanze ;
Doehner, Hartmut ;
Schlenk, Richard F. ;
Ganser, Arnold .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18) :3000-3006
[25]   H3K79 Methylation Profiles Define Murine and Human MLL-AF4 Leukemias [J].
Krivtsov, Andrei V. ;
Feng, Zhaohui ;
Lemieux, Madeleine E. ;
Faber, Joerg ;
Vempati, Sridhar ;
Sinha, Amit U. ;
Xia, Xiaobo ;
Jesneck, Jonathan ;
Bracken, Adrian P. ;
Silverman, Lewis B. ;
Kutok, Jeffery L. ;
Kung, Andrew L. ;
Armstrong, Scott A. .
CANCER CELL, 2008, 14 (05) :355-368
[26]   The Paf1 complex is required for histone h3 methylation by COMPASS and Dot1p: Linking transcriptional elongation to histone methylation [J].
Krogan, NJ ;
Dover, J ;
Wood, A ;
Schneider, J ;
Heidt, J ;
Boateng, MA ;
Dean, K ;
Ryan, OW ;
Golshani, A ;
Johnston, M ;
Greenblatt, JF ;
Shilatifard, A .
MOLECULAR CELL, 2003, 11 (03) :721-729
[27]   COMPASS, a histone H3 (lysine 4) methyltransferase required for telomeric silencing of gene expression [J].
Krogan, NJ ;
Dover, J ;
Khorrami, S ;
Greenblatt, JF ;
Schneider, J ;
Johnston, M ;
Shilatifard, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (13) :10753-10755
[28]   Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b [J].
Kroon, E ;
Krosl, J ;
Thorsteinsdottir, U ;
Baban, S ;
Buchberg, AM ;
Sauvageau, G .
EMBO JOURNAL, 1998, 17 (13) :3714-3725
[29]   Disruptor of telomeric silencing-1 is a chromatin-specific histone H3 methyltransferase [J].
Lacoste, N ;
Utley, RT ;
Hunter, JM ;
Poirier, GG ;
Côté, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (34) :30421-30424
[30]   Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome:: results of NOPHO-AML trials [J].
Lie, SO ;
Abrahamsson, J ;
Clausen, N ;
Forestier, E ;
Hasle, H ;
Hovi, L ;
Jonmundsson, G ;
Mellander, L ;
Gustafsson, G .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (02) :217-225